Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

GG Steger; R Greil; A Lang; M Rudas; F Fitzal; B Mlineritsch; BL Hartmann; R Bartsch; E Melbinger; M Hubalek; Herbert Stöger; P Dubsky; S Ressler; AL Petzer; CF Singer; C Muss; R Jakesz; SP Gampenrieder; CC Zielinski; C Fesl; M Gnant

doi:10.1093/annonc/mdt508

Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

GG Steger
, R Greil
, A Lang
, M Rudas
, F Fitzal
, B Mlineritsch
, BL Hartmann
, R Bartsch
, E Melbinger
, M Hubalek
, Herbert Stöger
, P Dubsky
, S Ressler
, AL Petzer
, CF Singer
, C Muss
, R Jakesz
, SP Gampenrieder
, CC Zielinski
, C Fesl

M Gnant

Division of Oncology

Research output: Contribution to journal › Research article

63 Citations (Web of Science)

Original language	English
Journal	Annals of Oncology
DOIs	https://doi.org/10.1093/annonc/mdt508
Publication status	Published - 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Branches of science

302 Clinical Medicine

Research Fields

Cancer Research

DOI

10.1093/annonc/mdt508

Links

Cite this

Steger, GG., Greil, R., Lang, A., Rudas, M., Fitzal, F., Mlineritsch, B., Hartmann, BL., Bartsch, R., Melbinger, E., Hubalek, M., Stöger, H., Dubsky, P., Ressler, S., Petzer, AL., Singer, CF., Muss, C., Jakesz, R., Gampenrieder, SP., Zielinski, CC., ... Gnant, M. (2014). Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24). Annals of Oncology. https://doi.org/10.1093/annonc/mdt508

@article{be245341b6ac46048edc399d89b77434,

title = "Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)",

author = "GG Steger and R Greil and A Lang and M Rudas and F Fitzal and B Mlineritsch and BL Hartmann and R Bartsch and E Melbinger and M Hubalek and Herbert St{\"o}ger and P Dubsky and S Ressler and AL Petzer and CF Singer and C Muss and R Jakesz and SP Gampenrieder and CC Zielinski and C Fesl and M Gnant",

year = "2014",

doi = "10.1093/annonc/mdt508",

language = "English",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Elsevier Ltd",

}

Steger, GG, Greil, R, Lang, A, Rudas, M, Fitzal, F, Mlineritsch, B, Hartmann, BL, Bartsch, R, Melbinger, E, Hubalek, M, Stöger, H, Dubsky, P, Ressler, S, Petzer, AL, Singer, CF, Muss, C, Jakesz, R, Gampenrieder, SP, Zielinski, CC, Fesl, C & Gnant, M 2014, 'Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)', Annals of Oncology. https://doi.org/10.1093/annonc/mdt508

TY - JOUR

T1 - Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24)

AU - Steger, GG

AU - Greil, R

AU - Lang, A

AU - Rudas, M

AU - Fitzal, F

AU - Mlineritsch, B

AU - Hartmann, BL

AU - Bartsch, R

AU - Melbinger, E

AU - Hubalek, M

AU - Stöger, Herbert

AU - Dubsky, P

AU - Ressler, S

AU - Petzer, AL

AU - Singer, CF

AU - Muss, C

AU - Jakesz, R

AU - Gampenrieder, SP

AU - Zielinski, CC

AU - Fesl, C

AU - Gnant, M

PY - 2014

Y1 - 2014

UR - https://www.webofscience.com/wos/woscc/full-record/WOS:000331269600011

UR - https://pubmed.ncbi.nlm.nih.gov/24347519

U2 - 10.1093/annonc/mdt508

DO - 10.1093/annonc/mdt508

M3 - Research article

C2 - 24347519

SN - 0923-7534

JO - Annals of Oncology

JF - Annals of Oncology

ER -